By Professor Glenda Halliday

Conference Papers

Woodhouse A; Carroll V; Sokolova A; Shepherd CE; Halliday GM; Dickson TC; Vickers J, 2008, 'Preseninil-1 familial Alzheimer's disease cases exhibit altered pathology in comparison to sporadic AD', in Proceedings of Aust Neuroscience Society, Hobart, pp. 113 - 113, presented at Australian Neuroscience Society 28th Annual Meeting, Hobart, 27 January 2008 - 30 January 2008

Halliday GM, 2007, 'Clinicopathological aspects of motor parkinsonism', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, presented at 17th World Congress on Parkinsons Disease and Related Disorders, Amsterdam, Netherlands, 09 December 2007 - 13 December 2007

Reid WG; Hely MA; Morris JG; Loy CT; Halliday GM, 2007, 'Dementia in Parkinson`s disease (PD): A 20-year prospective Sydney Multicentre study', in Movement Disorders, Wiley-Liss, Hoboken, NJ, USA, pp. 245S - 245S, presented at 11th International Congress of Parkinson`s Disease and Movement Disorders, Istanbul, Turkey, 03 June 2007 - 07 June 2007

Mastaglia F; Huang Y; Halliday GM; Rowe DB; Sue C, 2007, 'Novel LRKK2 mutation in the Roc domain in an Western Australian family with autosomal dominant late-onset Parkinson`s disease (LOPD)', in Movement Disorders, Wiley-Liss, Hoboken, NJ, USA, pp. 224S - 224S, presented at 11th International Congress of Parkinson`s Disease and Movement Disorders, Istanbul, Turkey, 03 June 2007 - 07 June 2007

Huang Y; Halliday GM; Vandebona H; Mellick GD; Mastaglia F; Stevens J; Kwok JB; Garlepp M; Silburn PA; Horne MK; Kotschet K; Venn A; Rowe DB; Rubio J; Sue C, 2007, 'Prevalence of LRRK2 mutations in Australians with Parkinson`s disease', in Movement Disorders, Wiley-Liss, Hoboken, NJ, USA, pp. 83S - 83S, presented at 11th International Congress of Parkinson`s Disease and Movement Disorders, Istanbul, Turkey, 03 June 2007 - 07 June 2007

Song YJC; Huang Y; Lundvig D; Gai WP; Blumbergs P; Hojrup P; Otzen D; Halliday G; Jensen P, 2007, 'P25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy', in PARKINSONISM & RELATED DISORDERS, ELSEVIER SCI LTD, pp. S63 - S63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000252212700133&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Halliday GM, 2006, 'Consequences of immune dysregulation in Parkinson`s disease', in 4th Congress of the Federation of Asian-Oceanian Neuroscience Societies and the 26th Scientific Meeting of the Hong Kong Society of Neurosciences, Hong Kong, pp. 2 - 2, presented at 4th Congress of the Federation of Asian-Oceanian Neuroscience Societies and the 26th Scientific Meeting of the Hong Kong Society of Neurosciences, Hong Kong, 30 November 2006 - 02 December 2006

Huang Y; Halliday GM, 2006, 'Alpha synuclein positive astrocytes in Lewy body disease', in 4th International Workshop on DLB and PDD, Yokohama, Japan, pp. 102 - 105, presented at 4th International Workshop on DLB and PDD, Yokohama, Japan, 02 November 2006 - 04 November 2006

Halliday GM, 2006, 'Identifying common and differentiating clinicopathologic features in prospectively-collected DLB & PDD', in 4th International Workshop on DLB and PDD, Yokohama, Japan, pp. 45 - 45, presented at 4th International Workshop on DLB and PDD, Yokohama, Japan, 02 November 2006 - 04 November 2006

Huang Y; Gai WP; Mccann H; Halliday GM, 2006, 'LRRK2 pathology in sporadic and alpha-synuclein A53T mutant Parkinson`s disease', in Movement Disorders, Wiley-Liss, Hoboken, NJ, USA, pp. S581 - S581, presented at 10th International Congress of Parkinson`s Disease and Movement Disorders, Kyoto, Japan, 30 October 2006 - 02 November 2006

Rowe DB; Morel-Kopp M; Orr CF; Russell T; Ranola M; Huang Y; Ward CR; Halliday GM, 2006, 'Selective activation of T cells in Parkinson`s disease', in Movement Disorders, Wiley-Liss, Hoboken, NJ, USA, pp. S606 - S606, presented at 10th International Congress of Parkinson`s Disease and Movement Disorders, Kyoto, Japan, 30 October 2006 - 02 November 2006

Double KL; Halliday GM, 2006, 'Neuromelanin-associated isoprenoids in the pathophysiology of Parkinson's disease', in MOVEMENT DISORDERS, WILEY-LISS, JAPAN, Kyoto, pp. S447 - S447, presented at 10th International Congress of Parkinson's Disease and Movement Disorders, JAPAN, Kyoto, 30 October 2006 - 02 November 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241058000439&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kersaitis C; Halliday G; Xuereb J; Pamphlett R; Bak T; Hodges J; Kril J, 2006, 'Ubiquitin positive inclusions and early pathology in frontotemporal lobar degeneration and motor neuron disease', in BRAIN PATHOLOGY, BLACKWELL PUBLISHING, CA, San Francisco, pp. S43 - S43, presented at 16th International Congress of Neuropathology, CA, San Francisco, 10 September 2006 - 15 September 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239938600095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Halliday GM, 2006, 'Staging frontotemporal dementia (FTD) pathology', in 5th International Conference on Frontotemporal Dementia, San Francisco, California USA, pp. 21 - 21, presented at 5th International Conference on Frontotemporal Dementia, San Francisco, California USA, 06 September 2006 - 08 September 2006

Damian DL; Patterson CR; Yiasemides E; Barnetson RS; Stapelberg M; Halliday GM, 2006, 'Topical nicotinamide (vitamin B3) prevents ultraviolet radiation-induced suppression of Mantoux reactions in humans', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, FRANCE, Paris, pp. 73 - 73, presented at 36th Annual Meeting of the European-Society-of-Dermatology-Research (ESDR), FRANCE, Paris, 06 September 2006 - 07 September 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000242891900426&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shepherd CE; Gregory GC; Warden LA; Halliday GM, 2006, 'Oligomeric AB40 species accumulate in the toxic plaques in Alzheimer's disease', in Khachaturian Z (ed.), Alzheimer's and Dementia, Elsevier, Orlando, Florida, pp. 107 - 107, presented at Alzheimer's Association 10th International Conference of Alzheimer's Disease and Related Disorders, Madrid, Spain, 15 July 2006 - 20 July 2006

Gotz J; David DJ; Ittner L; Halliday GM; Shepherd CE, 2006, 'Animal and cellular models - Tau-Abeta interaction', in Khachaturian Z (ed.), Alzheimer's and Dementia, Elsevier, Orlando, Florida, pp. S92 - S92, presented at Alzheimer`s Association 10th International Conference of Alzheimer`s Disease and Related Disorders, Madrid, Spain, 15 July 2006 - 20 July 2006

Halliday GM, 2006, 'The status of A-synuclein in Alzheimer cases with and without Lewy bodies', in Khachaturian Z (ed.), Alzheimers and Dementia, Elsevier, Orlando, Florida, pp. S25 - S25, presented at Alzheimer`s Association 10th International Conference of Alzheimer`s Disease and Related Disorders, Madrid, Spain, 15 July 2006 - 20 July 2006

Schofield EC; Mccredie RM; Halliday GM; Cordato N, 2006, 'Changes in regional cerebral blood flow relate to cognitive and behavioural symptoms in progressive supranuclear palsy', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 1024 - 1024, presented at Australian Association of Neurologists Annual Scientific Meeting 2006, Canberra, 01 May 2006 - 05 May 2006

Piguet O; Bennett HP; Waite LM; Kril J; Creasey H; Broe T; Halliday GM, 2006, 'Preserved cognition and functional independence after a large right PCA infarct: longitudinal clinical and neuropathological findings', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 1023 - 1023, presented at Australian Association of Neurologists Annual Scientific Meeting 2006, Canberra, 01 May 2006 - 05 May 2006

Stevens J; Huang Y; Vandenboma H; Halliday GM; Mellick GD; Mastaglia F; Kwok JB; Sue C, 2006, 'Prevalence of LRRK2 mutations in Australians with Parkinson`s disease', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 1009 - 1009, presented at Australian Association of Neurologists Annual Scientific Meeting 2006, Canberra, 01 May 2006 - 05 May 2006

Sutherland GR; Sue C; Mellick GD; Lee L; Rowe DB; Silburn PA; Halliday GM, 2006, 'Promotor polymorphisms lowering parkin expresssion reduce the age of onset of parkinson`s disease', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 1033 - 1033, presented at Australian Association of Neurologists Annual Scientific Meeting 2006, Canberra, 01 May 2006 - 05 May 2006

Brooks D; Harding AJ; Halliday GM, 2006, 'Visual hallucinations and fluctuating consciousness relate to pathology of limbic thalamus in Lewy body dementias', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 1025 - 1025, presented at Australian Association of Neurologists Annual Scientific Meeting 2006, Canberra, 01 May 2006 - 05 May 2006

Sutherland GT; Mellick GD; Double KL; Stevens J; Lee L; Rowe DB; Silburn PA; Halliday GM, 2006, 'An association between a tyrosine hydroxylase polymorphism and Parkinson`s disease', in Proceedings of Aust Neuroscience Society, Sydney, pp. 52 - 52, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Mevawalla N; Hardman CD; Mccann H; Halliday GM, 2006, 'Atrophy and pathological changes in the olfactory bulb in neurodegenerative diseases', in Proceedings of Aust Neuroscience Society, Sydney, pp. 152 - 152, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Brooks D; Harding AJ; Halliday GM, 2006, 'Atrophy of limbic thalamus relates to visual hallucinations and dementia in Lewy body diseases', in Proceedings of Aust Neuroscience Society, Sydney, pp. 58 - 58, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Gai WP; Shen XF; Chegini F; Blumbergs PC; Huang Y; Halliday GM, 2006, 'Characterization of LRRK2 protein in human brain and in Alzheimer's tangles and Parkinson's Lewy bodies', in Proceedings of Aust Neuroscience Society, Sydney, pp. 52 - 52, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Murphy KE; Double KL; Halliday GM, 2006, 'Differential expression of tyrosine hydroxylase isoforms in human substantia nigra', in Proceedings of Aust Neuroscience Society, Sydney, pp. 51 - 51, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Double KL; Halliday GM, 2006, 'Do changes in neuromelanin pigment in Parkinson`s disease provide clues to the aetiology of this disorder', in Proceedings of Aust Neuroscience Society, Sydney, pp. 42 - 42, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Shen XF; Chegini F; Huang Y; Halliday GM; Blumbergs PC; Gai WP, 2006, 'Leucine-rich repeat kinase 2 pathology in aged human brains and neurodegenerative diseases', in Proceedings of Aust Neuroscience Society, Sydney, pp. 147 - 147, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Shepherd CE; Grace E; Mann DM; Halliday GM, 2006, 'Novel inflammatory plaques are not associated with greater neuronal cell loss', in Proceedings of Aust Neuroscience Society, Sydney, pp. 151 - 151, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Stevens J; Huang Y; Vandebona H; Halliday GM; Mellick GD; Mastaglia F; Kwok JB; Garlepp M; Silburn PA; Rowe DB; Sue C, 2006, 'Prevalence of the common LRRK2 mutations in Australians with Parkinson`s disease', in Proceedings of Aust Neuroscience Society, Sydney, pp. 147 - 147, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Schofield E; Mccredie RM; Halliday GM; Cordato N, 2006, 'Progressive supranuclear palsy causes changes in regional cerebral blood flow', in Proceedings of Aust Neuroscience Society, Sydney, pp. 57 - 57, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Rahimi F; Raftery MJ; Halliday GM; Geczy C; Shepherd CE, 2006, 'Proteomic analysis of formalin-fixed brain tissue is potentially applicable to laser-microdissected specimens', in Proceedings of Aust Neuroscience Society, Sydney, pp. 41 - 41, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Harding AJ; Davis DG; White LR; Halliday GM, 2006, 'Sampling method affects clinicopathological relationships', in Proceedings of Aust Neuroscience Society, Sydney, pp. 158 - 158, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Song YC; Huang Y; Gai WP; Jensen PH; Halliday GM, 2006, 'Selective loss of P25A in multiple system atrophy', in Proceedings of Aust Neuroscience Society, Sydney, pp. 152 - 152, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Yadav S; Hardman CD; Mccann H; Halliday GM, 2006, 'The dentate nucleus in progressive supranuclear palsy', in Proceedings of Aust Neuroscience Society, Sydney, pp. 153 - 153, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Huang Y; Sutherland GT; Lee L; Rowe DB; Halliday GM, 2006, 'The interaction of alpha-synuclein and tau genes on the progression of Parkinson`s disease', in Proceedings of Aust Neuroscience Society, Sydney, pp. 149 - 149, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Young VG; Halliday GM; Kril J, 2006, 'The relationship between white matter hyperintensities and glial density', in Proceedings of Aust Neuroscience Society, Sydney, pp. 156 - 156, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Kersaitis C; Halliday GM; Xuereb J; Pamphlett R; Bak T; Hodges JR; Kril J, 2006, 'Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neuron disease identifies a group with mainly early pathology', in Proceedings of Aust Neuroscience Society, Sydney, pp. 152 - 152, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006

Halliday GM, 2005, 'Diffuse Lewy body disease', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S22 - S22, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Schofield E; Cordato N; Macdonald V; Kril J; Halliday GM, 2005, 'Does cellular pathology predict atrophy in progressive supranuclear palsy? A study of the caudate nucleus', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S329 - S329, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Huang Y; Rowe DB; Cook NL; Halliday GM, 2005, 'Genetic variation in IL-10 influences the progression of Parkinson`s disease', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S355 - S355, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Orr CF; Rowe DB; Morel-Kopp M; Ward CR; Russell T; Ranola M; Halliday GM, 2005, 'Humoral immunity to oxidised alph-synuclein in Parkinson`s disease', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S367 - S367, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Cook NL; Huang Y; Gartner C; Mellick GD; Mastaglia F; Garlepp M; Silburn PA; Rowe DB; Halliday GM, 2005, 'Inflammation-related genes affect age onset of Parkinson`s disease', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S355 - S355, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Stevens J; Sutherland GR; Lee L; Double KL; Rowe DB; Halliday GM, 2005, 'Lack of association between a functional polymorphism in the tyrosine hydroxylase gene and Parkinson`s disease', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S158 - S158, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Kipps CM; Davies R; Mitchell J; Kril J; Halliday GM; Hodges JR, 2005, 'Lobar atrophy and progression in frontotemporal dementia: identification of a benign behavioural variant', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S282 - S282, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Song YC; Halliday GM; Creasey H; Morris JG; Brooks WS; Kril J, 2005, 'Neuropathology in the S305S tau gene mutation', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S302 - S302, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Rahimi F; Goyette J; Raftery MJ; Shepherd CE; Halliday GM; Geczy C, 2005, 'S100A9, an inflammation-associated calcium-binding protein, is a binding partner for various redox-regulating proteins in familial Alzheimer's disease', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S298 - S298, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Sutherland GR; Nowak G; Halliday GM; Kril J, 2005, 'Tau isoform expression in frontotemporal dementia with motor neuron inclusions', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S303 - S303, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Back to profile page